blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2538972

EP2538972 - RECOMBINANT CDV COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2019
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  23.03.2018
FormerGrant of patent is intended
Status updated on  16.03.2018
FormerExamination is in progress
Status updated on  22.02.2018
FormerGrant of patent is intended
Status updated on  15.10.2017
FormerExamination is in progress
Status updated on  08.02.2017
Most recent event   Tooltip01.03.2019No opposition filed within time limitpublished on 03.04.2019  [2019/14]
Applicant(s)For all designated states
Merial, Inc.
3239 Satellite Boulevard
Bldg. 500
Duluth, GA 30096 / US
[2017/38]
Former [2013/01]For all designated states
Merial Limited
3239 Satellite Blvd.
Duluth, GA 30096 / US
Inventor(s)01 / AUDONNET, Jean-Christophe
119, Rue De Crequi
69006 Lyon / FR
02 / MINKE, Jules
16 Rue Nicolas Boileau
69960 Corbas / FR
 [2013/01]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2018/17]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2013/01]Harding, Charles Thomas
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date11707047.425.02.2011
[2018/17]
WO2011US26378
Priority number, dateUS20100308620P26.02.2010         Original published format: US 308620 P
[2013/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011106743
Date:01.09.2011
Language:EN
[2011/35]
Type: A1 Application with search report 
No.:EP2538972
Date:02.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 01.09.2011 takes the place of the publication of the European patent application.
[2013/01]
Type: B1 Patent specification 
No.:EP2538972
Date:25.04.2018
Language:EN
[2018/17]
Search report(s)International search report - published on:EP01.09.2011
ClassificationIPC:A61K39/12, A61K39/175, A61K39/205, A61K39/23, C07K14/015, C07K14/12, C07K14/13, C07K14/145, C07K14/165, C12N7/00, C12N7/04, C12N15/86
[2013/01]
CPC:
A61K39/12 (EP,KR,US); A61K48/005 (KR); A61K39/175 (KR,US);
A61K39/205 (KR); A61N5/0613 (US); A61P31/10 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP);
A61P31/20 (EP); A61P31/22 (EP); A61P33/02 (EP);
A61P37/04 (EP); C07K14/005 (EP,KR,US); C07K14/535 (EP,KR,US);
C12N7/00 (US); A61K2039/53 (EP,KR,US); A61K2039/545 (EP,KR,US);
A61K2039/552 (EP,KR,US); A61K2039/55522 (EP,KR,US); C12N2710/24043 (EP,US);
C12N2750/14334 (EP,US); C12N2760/18422 (EP,US); C12N2760/18434 (EP,KR,US);
C12N2760/18471 (EP,US); C12N2800/22 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:REKOMBINANTE CDV-ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG[2013/01]
English:RECOMBINANT CDV COMPOSITIONS AND USES THEREOF[2013/01]
French:COMPOSITIONS DE CDV RECOMBINANT ET LEURS UTILISATIONS[2013/01]
Entry into regional phase20.09.2012National basic fee paid 
20.09.2012Designation fee(s) paid 
20.09.2012Examination fee paid 
Examination procedure19.09.2012Amendment by applicant (claims and/or description)
20.09.2012Examination requested  [2013/01]
04.04.2014Despatch of a communication from the examining division (Time limit: M04)
16.06.2014Reply to a communication from the examining division
15.12.2014Despatch of a communication from the examining division (Time limit: M04)
03.03.2015Reply to a communication from the examining division
17.09.2015Despatch of a communication from the examining division (Time limit: M04)
26.11.2015Reply to a communication from the examining division
11.01.2017Cancellation of oral proceeding that was planned for 17.01.2017
17.01.2017Date of oral proceedings (cancelled)
30.01.2017Despatch of a communication from the examining division (Time limit: M02)
22.03.2017Reply to a communication from the examining division
16.10.2017Communication of intention to grant the patent
06.02.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.02.2018Fee for grant paid
16.02.2018Fee for publishing/printing paid
15.03.2018Information about intention to grant a patent
15.03.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.04.2014
Opposition(s)28.01.2019No opposition filed within time limit [2019/14]
Fees paidRenewal fee
27.02.2013Renewal fee patent year 03
27.02.2014Renewal fee patent year 04
26.02.2015Renewal fee patent year 05
26.02.2016Renewal fee patent year 06
27.02.2017Renewal fee patent year 07
27.02.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]US5702919  (NASH RICHARD A [US], et al) [X] 1,7,8,12,15 * abstract * * column 2, line 13 - line 39 * * column 7, line 26 - line 63 * [Y] 2-5,13 [I] 9-11,16-18;
 [XYI]WO9749825  (MERIAL SAS [FR], et al) [X] 1,6,8,9,12,14,16,17 * abstract * * page 3, line 20 - line 25 * * page 5, line 5 - line 27 * * examples 7, 8, 11-14 * [Y] 2-5,13 [I] 18;
 [XYI]FR2775601  (MERIAL SAS [FR]) [X] 1,6,8,9,12,14,16,17 * abstract * * page 5, line 17 * * page 6, line 16 - page 7, line 1 * * example 2 * [Y] 2-5,13 [I] 18;
 [XYI]US6309647  (PAOLETTI ENZO [US], et al) [X] 1,6,8,9,12,14,16,17 * abstract * * column 1, line 8 - line 14 * * column 7, line 5 - line 9 * * column 8, line 3 - line 7 * * column 10, line 26 - line 34 * * examples 14, 16, 18-19, 21-23 * [Y] 2-5,13 [I] 18;
 [X]US2005255127  (LOOSMORE SHEENA M [CA], et al) [X] 1-18 * abstract * * paragraph [0144] - paragraph [0146] * * paragraph [0160] *;
 [XYI]  - FISCHER L ET AL, "Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge", VACCINE, ELSEVIER LTD, GB, (20021004), vol. 20, no. 29-30, doi:DOI:10.1016/S0264-410X(02)00344-4, ISSN 0264-410X, pages 3485 - 3497, XP004381813 [X] 1,6,8,9,12,14,16,17 * abstract * * page 3486, column l, line 36 - line 44 * * 2.4 Engineering of expression cassettes.; page 3487 * * 2.5. Cloning of CDV HA and F; page 3487 - page 3488 * * 2.7. Generation of recombinant CAV2 viruses by in vitro recombination.; page 3488 * * 2.10. Vaccination and protection assays.; page 3488 - page 3489 * [Y] 2-5,13 [I] 18

DOI:   http://dx.doi.org/10.1016/S0264-410X(02)00344-4
 [A]  - NIELSEN LINE ET AL, "Changes in the receptorbinding haemagglutinin protein of wild-type morbilliviruses are not required for adaptation to Vero cells.", VIRUS GENES, (200310), vol. 27, no. 2, ISSN 0920-8569, pages 157 - 162, XP002639102 [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1023/A:1025724526378
 [XYI]  - NASH R A ET AL, "MOLECULAR CLONING AND IN-VIVO EVALUATION OF CANINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR", BLOOD, (1991), vol. 78, no. 4, ISSN 0006-4971, pages 930 - 937, XP002639103 [X] 1,7,8,12,15,17 * abstract * * page 935, column r * [Y] 2-5,13 [I] 9-11,16,18
 [A]  - JONES T ET AL, "POTENTIAL ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS VACCINE ADJUVANT", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, SPRINGER, WIESBADEN, DE, (19940101), vol. 13, no. SUPPL. 02, doi:DOI:10.1007/BF01973602, ISSN 0934-9723, pages 47 - 53, XP002009623 [A] 1-18 * abstract * * page S49, line 20 - line 30 * * Approaches for Use of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor as a Vaccine Adjuvant.; page S52 *

DOI:   http://dx.doi.org/10.1007/BF01973602
by applicantUS2909462
 US4708871
 US5122458
 US5494807
 US5505941
 WO9634109
 US5606024
 US5702919
 WO9816247
 US5756102
 US5846946
 WO9901158
 US6221362
 US6358500
 US6376473
 US6451769
 US6451770
 US6464984
 US6558674
 US6576243
 US6586412
 US2004022605
 US6818628
 US6852705
 US6919084
 US7250161
 US7371395
    - FENNER ET AL., Veterinary Virology, ACADEMIC PRESS, INC., (1987), pages 485 - 503
    - GRAVES ET AL., VIROLOGY, (1978), vol. 86, pages 254 - 263
    - DIALLO A., VET. MICRO., (1990), vol. 23, pages 155 - 163
    - BURGESS ET AL., J. BIOL. CHEM., (1977), vol. 252, pages 1998 - 2003
    - DY M., les Cytokines, MASSON, (1995), pages 43 - 56
    - CANTRELL ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 6250 - 6254
    - PHARMEUROPA, (199606), vol. 8, no. 2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.